Cancer cell–selective in vivo Treating cancer with light activated, antibody-dye conjugates by Amol Kapoor and Teddy Leithead Makoto Mitsunaga, Mikako.

Slides:



Advertisements
Similar presentations
Progress Against Kidney Cancer. 1970–1979 Progress Against Kidney Cancer 1970– : Removing just part of the cancerous kidney is proven safe and.
Advertisements

Immune therapy in NSCLC Presentation – 劉惠文 Supervisor – 劉俊煌教授.
Targeted Cancer Therapeutics, LLC Investor Presentation.
Radioimmunotherapy Allison Spencer July 27, 2006.
MIGSYS Ian Evans, Genetics Max Musicant, SOM Grant Patterson, EPH Jia Kang, Med Informatics Colin Shaw, Nursing YBPS Case Competition November 20, 2009.
GROUP 5 Monoclonal Antibodies for Cancer Treatment.
MONOCLONAL ANTIBODIES
Akadeemia tee 21 Tallinn Estonia Reg.nr.: InBio Ltd. ANTIBODIES FOR THERAPEUTIC AND DIAGNOSTIC APPLICATIONS.
{ Targeting and killing of malignant gliomas by specific stem cells expressing a suicide gene.
Cancer’s Trojan Horse Student ChE 391 October 3, 2002.
New Developments in Cancer Treatment Dulcinea Quintana, MD.
Evaluating Potential Drug Therapies Mike Shuler Biomedical Engineering.
Advanced Cancer Topics Journal Review 4/16/2009 AD.
Photo-therapy K.O. Lenz BMS Wilmington, DE. Photo-therapy.
Annual prostate cancer symposium February 23, 2013 The Kimmel Cancer Center, Philadelphia, PA 2nd “ Novel Therapeutic Strategies for Prostate Cancer ”
Biomedical Research.
Insert Program or Hospital Logo Introduction Melanoma is notoriously resistant to chemotherapy. While surgical resection and adjuvant chemotherapy can.
Regrowing hair with laser and light sources: Is this practical? Michael R Hamblin PhD.
Nanotechnology in Cancer Treatment
Antibody and prodrug therapy of cancer
Akadeemia tee 21 Tallinn Estonia Reg.nr.: InBio Ltd. ANTIBODIES FOR THERAPEUTIC AND DIAGNOSTIC APPLICATIONS.
Zacchigna M. (a), Cateni F. (a), Drioli S. (a), Bonora GM. (a), Zorzet S. (b), Rapozzi V. (c), Xodo L.E. (c) (a) Department of Chemical and Pharmaceutical.
Fighting Cancer with Gold Nanoshells.
By: LaShanale Wallace.  Introduction: What is Autophagy?  Objective  Specific examples  Conclusion.
What is gene therapy? Do now: In your own words,
Nanoparticle is a general term covering any structure built on a nanometer scale. In medical science, nanoparticles are structures on a nm scale,
Gold Nanorods for Medical Treatment By Jessie Morales.
Photodynamic Therapy Lamar Institute of Technology Presented by: Amber Burks Dental Hygiene Student Danielle Chelette Dental Hygiene Student.
Pancreatic Cancer in the US – 12/2015 TIMOTHY PAULUS - TESTIMONY 1/20/2016.
Nanomedicine - Medicine of the future. Medical application of nanotechnology – Nanotechnology: the study of the control of matter at the atomic/molecular.
Progress in Cancer Therapy Following Developments in Biopharma
Responses to Subsequent Anti-HER2 Therapy After Treatment with Trastuzumab-DM1 in Women with HER2- Positive Metastatic Breast Cancer 1 A Phase Ib/II Trial.
Cancer Therapies DNA microarrays are used to assess the relative expression of thousands of genes simultaneously—relative expression means that.
CANCER THERAPY  Surgery  Radiation Therapy  Chemotherapy  Stem Cell Transplant  Immunotherapy  Targeted Therapy  Hormone Therapy  Precision Medicine.
多肽类药物研究的新进展 潘婷婷 多肽药物定义: 通常将含有的氨基酸少于 10 个的肽称为寡肽,超过的就 称为多肽。所以多肽药物可以这样说: 从生物化学本质上说是一种肽,具有 10 个氨基酸以上; 从功能上讲具有药物的功能,能用于疾病的预防、治疗与 诊断。
Bijoy Telivala, MD Advances in Immunotherapy Bijoy Telivala, MD
Alternative Treatments for Localized Prostate Cancer
Metastatic Head Neck Cancer and Immunotherapy
0.05 mg/kg, DLI – 24 hours, dose of light – 40 J/cm2
Intention-to-treat population
Figure 5. Treatment of the checkpoint inhibitor related toxicity
Targeted therapies in hematological malignancies using therapeutic monoclonal antibodies against Eph family receptors  Sara Charmsaz, Andrew M. Scott,
iRGD, a tumor-penetrating peptide for tumor-specific drug delivery
Antibody Drug Conjugates Services Antibody-drug conjugates Antibody-drug conjugates (ADCs) are a very important class of highly potent drugs designed as.
Globular Protein Made of amino acid chains
Intervista a Lucio Crinò
Anti-therapeutic antibodies Creative Biolabs is a pioneer and undisputed global leader in the rapidly emerging market for therapeutic antibodies. We offer.
What is antibody screening While conventional cancer therapies (surgery, chemo therapy, and radiation therapy) have shown some success in the battle again.
Therapeutic antibodies Creative Biolabs is a pioneer and undisputed global leader in the rapidly emerging market for therapeutic antibodies. We offer a.
Anti-therapeutic antibodies Creative Biolabs is a pioneer and undisputed global leader in the rapidly emerging market for therapeutic antibodies. We offer.
Immunotherapy of hepatocellular carcinoma
An Introduction to DNA Damage Repair in Cancer: Beyond PARP
Trinity College Dublin 12 April 2018 Hugh McMahon
Discussion Outline Cells of the Immune System.
The Nurse View: Best Practices in Advanced Non-Small Cell Lung Cancer
Conjugates of folic acids with BSA coated quantum dots for cancer cell targeting and imaging by single-photon and two-photon excitations He Meng, Ji-Yao.
New Mexico Highlands University Morehouse College Georgia Institute of Technology Light-Matter Interactions: Theory and Applications (LMITA) Photodynamic.
Regulating the Cell Cycle
Advancing the Treatment of IBD With Biologics
This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were.
Figure 2 Host immune responses, not the radiosensitivity
Implementing Genome-Driven Oncology
Targeted therapies in hematological malignancies using therapeutic monoclonal antibodies against Eph family receptors  Sara Charmsaz, Andrew M. Scott,
Optimizing Targeted Therapy for HER2-Positive Advanced Breast Cancer: Considerations for Previously Treated Disease.
A Closer Look.
Nanotechnology (Kanzius Machine)
Maximizing Disease-Free Survival in Early-Stage HER2-Positive Breast Cancer.
Using Q-learning Method in Identify Optimal Treatment Regime
Cabozantinib causes significant tumor cell elimination in vivo, but modest apoptosis induction in vitro. Cabozantinib causes significant tumor cell elimination.
Uncovering the Right Sequence
Presentation transcript:

Cancer cell–selective in vivo Treating cancer with light activated, antibody-dye conjugates by Amol Kapoor and Teddy Leithead Makoto Mitsunaga, Mikako Ogawa, Nobuyuki Kosaka, Lauren Rosenblum, Peter L Choyke & Hisataka Kobayashi near infrared photoimmunotherapy targeting specific membrane molecules

Overview Cancer treatments focus on minimal side effects with maximal cancer cell death Photoimmunotherapy (PIT) IR700 + Trastuzumab and Panitumumab. IR700 toxic only when bound Specific antibodies could allow for the treatment of many cancers

Background Photo Dynamic Therapy (PDT) Excited photosensitizers -> Singlet oxygen Singlet oxygen -> cell death Immunotherapy  Uses the body's defense mechanism  Antibodies

Introduction PIT = PDT + Immunotherapy PDT -> Toxicity Immunotherapy -> Specificity PIT makes a strong therapy because of low healthy cell death

Review PDT PIT Immunotherapy

Results-In Vitro 73%78% 3T3-HER2 cells and A431 HER1 cells Significant cell death from both conjugates Irradiation -> Cell death

Results-In Vitro (Cont.) Tra-IR toxic only when bound Cellular uptake is unnecessary

Results-In Vivo

Results-In Vivo (Cont.) Tumor size Life span Rats w/ treatment Repeated treatment of drug led to tumor free survival at over four months

Discussion IR700 is hydrophilic and has high extinction coefficient More effective than other photosensitizers. mAb-1700 is highly selective Conjugate is non-toxic when unbound from Kobayashi: Mechanism of action and FDA trials

Conclusion/Summary A target specific PIT was developed NIR light irradiation + the conjugate leads to large cancer cell death Highly effective in vitro and in vivo

Future Research For clinical trials, mAb-IR700’s toxicity mechanism must be understood Researchers must confirm a minimal threat to non- cancerous cells Unique mAbs -> PIT applied to multiple cancers for diagnosis and treatment

Why It Matters Completely Revolutionizes Field Potentially makes other drugs obsolete The likelihood of one of us getting cancer is high. Perfected, this offers a way to stop all cancers.